Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Infinium PharmachemNSE:INFINIUM +0.57%87 EV-to-FCF is 14.90 as of Jul. 21, 2026, which is 91% below its 10-year median of 162.64. GuruFocus rates NSE:INFINIUM with a GF Score™ of 87/100 and a GF Value™ of ₹305.70 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 926 Chemicals companies, Infinium Pharmachem ranks better than 64.47% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Infinium Pharmachem's Enterprise Value is ₹3,582 Mil.
Infinium Pharmachem's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹240 Mil. Therefore, Infinium Pharmachem's EV-to-FCF for today is 14.90.
The historical rank and industry rank for Infinium Pharmachem's EV-to-FCF or its related term are showing as below:
NSE:INFINIUM'
s EV-to-FCF Range Over the Past 10 Years
Min: -13.23 Med: 162.64 Max: 369.12
Current: 14.82
During the past 7 years, the highest EV-to-FCF of Infinium Pharmachem was 369.12. The lowest was -13.23. And the median was 162.64.
NSE:INFINIUM's EV-to-FCF is ranked better than 64.47% of 926
companies
in the Chemicals industry
Industry Median: 21.335
vs NSE:INFINIUM: 14.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Infinium Pharmachem's PE Ratio (TTM) for today is calculated as:
Infinium Pharmachem's share price for today is ₹210.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.800.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Infinium Pharmachem EV-to-FCF Related Terms
Infinium Pharmachem EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Infinium Pharmachem's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Infinium Pharmachem EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Infinium Pharmachem's EV-to-FCF falls into.
Infinium Pharmachem's current Enterprise Value is ₹3,582 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹240 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem (NSE:INFINIUM) has a EV-to-FCF of 14.90 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Infinium Pharmachem and its competitors. This is 91% below median its historical median of 162.64. According to the industry distribution chart, Infinium Pharmachem ranks #329 out of 926 companies in the Chemicals industry, placing it in the top 35.5%.
Is Infinium Pharmachem's EV-to-FCF too high?
Infinium Pharmachem's current EV-to-FCF of 14.90 is 91% below median its 10-year median of 162.64. The Chemicals industry median EV-to-FCF is 21.34. Infinium Pharmachem's value of 14.90 is 30.2% below this industry median. Based on the distribution chart, Infinium Pharmachem ranks #329 out of 926 companies in the Chemicals industry, which is above the industry midpoint. Overall, Infinium Pharmachem has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's EV-to-FCF compare to DOW?
According to the Chemicals industry distribution chart, Infinium Pharmachem ranks #329 out of 926 companies for EV-to-FCF. This puts Infinium Pharmachem in the upper half of its industry. The industry median EV-to-FCF is 21.34. Infinium Pharmachem's value of 14.90 is 30.2% below this benchmark. While the company's 10-year median is 162.64 vs. the industry median of 21.34, Infinium Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Chemicals company?
The median EV-to-FCF among Chemicals companies is 21.34, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Infinium Pharmachem's current EV-to-FCF of 14.90 is 30.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Infinium Pharmachem and its competitors. For the Chemicals industry, the median EV-to-FCF is 21.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Infinium Pharmachem's current EV-to-FCF is 14.90, which is 91% below median its own 10-year median of 162.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹305.70, compared to a current price of ₹210.70 — trading 31.1% below its estimated fair value. The current EV-to-FCF is 14.90, which is 91% below median its 10-year median of 162.64 and 30.2% below the Chemicals industry median of 21.34. Infinium Pharmachem's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current EV-to-FCF is 14.90 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹210.70 is trading 31.1% below its estimated GF Value™ of ₹305.70.
GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.
Key valuation signals for NSE:INFINIUM:
EV-to-FCF: 14.90 (91% below median its 10-year median of 162.64)
GF Value™: ₹305.70 vs. price of ₹210.70 (31.1% below fair value)
Industry Position: 30.2% below the Chemicals median (#329 of 926)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
87GF Score
Get the complete analysis for NSE:INFINIUM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
